Leber Congenital Amaurosis (LCA) Recruiting Phase 1 / 2 Trials for Prednisone (DB00635)

Also known as: Leber Congenital Amaurosis / Leber's congenital amaurosis / Leber amaurosis

IndicationStatusPhase
DBCOND0078806 (Leber Congenital Amaurosis (LCA))Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03920007Study of Subretinally Injected SAR439483 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2DTreatment